Wall Street is my passion and I love pursuing it but with a pen ! After my Master's in Journalism, I joined Bio Pharma Journal as a freelance writer and was soon promoted to an associate editor position.
CymaBay Therapeutics Inc (NASDAQ: CBAY) has announced the presentation of promising seladelpar findings in primary biliary cholangitis (PBC) patients at The International Liver Congress...